Ratings by Jefferies (Biren Amin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/13/2025 | Immatics | IMTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2024 | Agenus Inc. | AGEN | Downgrade | Hold (Buy) |
7.30 (2.92) |
-60% | Details | |
| 3/4/2024 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2023 | Gracell Biotechnologies Inc | GRCL | Downgrade | Hold (Buy) |
6.19 (10.25) |
65.59% | Details | |
| 8/11/2023 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | Neurocrine Bio. | NBIX | Downgrade | Neutral (Buy) |
91.89 (166.06) |
80.72% | Details | |
| 10/8/2021 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | Legand Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2021 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2021 | Humanigen | HGEN | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2021 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Allogene | ALLO | New Coverage | Buy (N/A) |
24.69 (2.70) |
-89.06% | Details | |
| 6/4/2021 | Constellation Pharmaceuticals | CNST | Downgrade | Hold (Buy) |
33.57 (33.99) |
1.25% | Details | |
| 6/2/2021 | Legand Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2021 | Immatics | IMTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2021 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2021 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | Cortexyme Inc. | CRTX | Downgrade | Hold (Buy) |
47.47 (1.95) |
-95.89% | Details | |
| 2/10/2021 | Kadmon Holdings | KDMN | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2021 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2021 | Gracell Biotechnologies Inc | GRCL | New Coverage | Buy (N/A) |
20.72 (10.25) |
-50.53% | Details | |
| 1/15/2021 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2021 | BioAtla Inc. | BCAB | New Coverage | Buy (N/A) |
37.83 (3.79) |
-89.98% | Details | |
| 12/22/2020 | Humanigen | HGEN | New Coverage | Buy (N/A) |
15.51 (7.97) |
-48.61% | Details | |
| 12/21/2020 | Zentalis Pharmaceuticals | ZNTL | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2020 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2020 | Urovant Ltd. | UROV | Maintain | Hold (N/A) |
|
Details | ||
| 11/6/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2020 | C4 Therapeutics | CCCC | New Coverage | Buy (N/A) |
26.23 (4.25) |
-83.8% | Details | |
| 10/19/2020 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
21.05 (20.52) |
-2.52% | Details | |
| 9/18/2020 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2020 | Kala Pharmaceuticals | KALA | Downgrade | Hold (Buy) |
8.91 (3.00) |
-66.33% | Details | |
| 8/11/2020 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2020 | CytomX Therapeutics | CTMX | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | Immunogen Inc. | IMGN | Maintain | Hold (N/A) |
|
Details | ||
| 7/24/2020 | Immatics | IMTX | New Coverage | Buy (N/A) |
11.24 (10.02) |
-10.85% | Details | |
| 7/20/2020 | Constellation Pharmaceuticals | CNST | New Coverage | Buy (N/A) |
29.10 (33.99) |
16.8% | Details | |
| 7/14/2020 | Forma Therapeutics | FMTX | New Coverage | Buy (N/A) |
43.54 (24.26) |
-44.28% | Details | |
| 7/7/2020 | Vaxcyte | PCVX | New Coverage | Buy (N/A) |
29.38 (53.87) |
83.36% | Details | |
| 7/1/2020 | Legand Biotech Corp. | LEGN | New Coverage | Buy (N/A) |
41.10 (29.38) |
-28.52% | Details | |
| 6/29/2020 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Cortexyme Inc. | CRTX | New Coverage | Buy (N/A) |
46.09 (1.95) |
-95.77% | Details | |
| 6/1/2020 | CytomX Therapeutics | CTMX | Downgrade | Hold (Buy) |
8.73 (3.32) |
-61.97% | Details | |
| 5/29/2020 | Minerva Neurosciences | NERV | Downgrade | Hold (Buy) |
13.47 (4.33) |
-67.85% | Details | |
| 5/18/2020 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2020 | Zentalis Pharmaceuticals | ZNTL | Maintain | Neutral (Buy) |
|
Details | ||
| 3/27/2020 | Calithera Biosciences | CALA | New Coverage | Buy (N/A) |
4.20 (0.00) |
-100% | Details | |
| 2/25/2020 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
403.15 (623.43) |
54.64% | Details | |
| 2/14/2020 | Immunogen Inc. | IMGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/6/2020 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/5/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Synothorx Inc. | THOR | Downgrade | Hold (Buy) |
67.95 (24.93) |
-63.31% | Details | |
| 11/8/2019 | AnaptysBio | ANAB | Downgrade | Hold (Buy) |
36.16 (58.48) |
61.73% | Details | |
| 10/14/2019 | IGM Biosciences | IGMS | New Coverage | Buy (N/A) |
17.43 (17.20) |
-1.32% | Details | |
| 10/10/2019 | The Medicines Company | MDCO | Downgrade | Hold (Buy) |
50.97 (84.90) |
66.57% | Details | |
| 10/1/2019 | Minerva Neurosciences | NERV | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Bicycle Therapeutics | BCYC | New Coverage | Buy (N/A) |
12.40 (3.96) |
-68.06% | Details | |
| 5/30/2019 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2019 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 3/20/2019 | Advaxis | ADXS | Maintain | Hold (N/A) |
|
Details | ||
| 3/14/2019 | Kala Pharmaceuticals | KALA | New Coverage | Buy (N/A) |
8.21 (8.91) |
8.53% | Details | |
| 3/13/2019 | Synothorx Inc. | THOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2019 | TCR2 Therapeutics | TCRR | New Coverage | Buy (N/A) |
18.02 (1.48) |
-91.79% | Details | |
| 3/1/2019 | Immunogen Inc. | IMGN | Downgrade | Hold (Buy) |
4.72 (31.25) |
562.08% | Details | |
| 1/2/2019 | Synothorx Inc. | THOR | New Coverage | Buy (N/A) |
17.38 (24.93) |
43.44% | Details | |
| 12/13/2018 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Equillium | EQ | New Coverage | Buy (N/A) |
15.03 (2.85) |
-81.04% | Details | |
| 11/5/2018 | Fate Therapeutics | FATE | New Coverage | Buy (N/A) |
13.61 (85.34) |
527.04% | Details | |
| 11/5/2018 | Allogene | ALLO | New Coverage | Buy (N/A) |
26.95 (2.05) |
-92.39% | Details | |
| 10/22/2018 | Urovant Ltd. | UROV | New Coverage | Buy (N/A) |
12.19 (16.24) |
33.22% | Details | |
| 10/10/2018 | Trevena | TRVN | Downgrade | Hold (Buy) |
1.07 (2.50) |
133.64% | Details | |
| 8/24/2018 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
4.20 (7.68) |
82.86% | Details |
